OWC PHARMACEUTICAL RESEARCH

OWC PHARMACEUTICAL RESEARCH

OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system. In addition, it provides consulting services to companies and govern... mental agencies related to international medical cannabis protocols and regulations. The company was formerly known as Dynamic Applications Corp. and changed its name to OWC Pharmaceutical Research Corp. in December 2014. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel.

Owc Pharmaceutical Research_logo

Industry:
Corporation

Address:
2 Ben Gurion Street, Ramat Gan, Israel Zipcode 5257334

Country:
Israel

Phone:
972 72 260 8004

Market Cap:
4.73M
Total Assets:
3.55M
Total Cash:
3.46M

CEOs: Mordechai Bignitz · Ziv Turner


Key Executives
Name Title Pay Year Born
Mr. Alon Sinai Chief Operating Officer 94,000$ 1967(53 years old)
Dr. Yehuda Baruch Chief Medical & Regulatory Affairs Officer 112,000$ 1957(63 years old)
Mr. Ziv Turner Chief Exec. Officer N/A 1973(47 years old)
Mr. Shmuel De-Saban CFO & Sec. N/A 1966(54 years old)
Dr. Oron Yacoby-Zeevi Chief Scientific Officer N/A 1961(59 years old)
Prof. Yuval Ramot Consultant N/A N/A



Financial & Stock
Company's stock symbol is OWCP. Lastest price : 0.0095. Total volume :304.70k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.owcpharma.com

  • Host name: s-vps-il-100.upress.io
  • IP address: 88.218.116.151
  • Location: Rehovot Israel
  • Latitude: 31.8943
  • Longitude: 34.8192
  • Timezone: Asia/Jerusalem

Loading ...
Loading ...


More informations about "Owc Pharmaceutical Research" on Search Engine

Owcpharma.com OWC research is dedicated to provide patients with the assurance that they are using products that are chemically characterized, clinically tested, safe to use and efficient. Product development and manufacturing are conducted according to the Israeli Ministry of Health and quality regulations (such as: GAP, GLP GMP and GCP).

Owcpharma.com Research overview - OWC Pharmaceutical Research Corp

Owcpharma.com SEC Releases Press Releases Corporate Governance Investors Contact SEC …

Owcpharma.com About Us Team News & Events Transforming cannabis into scientifically proven and …

Owcpharma.com We’d like to hear from you Please complete the form below and we will get back to you …

Owcpharma.com Care for Skin Diseases - Research - OWC Pharmaceutical ...

Owcpharma.com OWC Pharmaceutical Research Corp. to report progress in clinical trials for ointment care …

Owcpharma.com Multiple Myeloma - Research - OWC Pharmaceutical Research Corp

Owcpharma.com SEC Releases Press Releases Corporate Governance Investors Contact …

Owcpharma.com Mr. De-Saban has acted as CFO of OWC pharmaceutical research corp. and OWC …

Owcpharma.com About Us Team News & Events Press Releases Events VIDEOS AND …

OWC PHARMACEUTICAL RESEARCH COR (OWCP) Stock Price, …

Finance.yahoo.com OWC Pharmaceutical Research Corp. (OTCQB: OWCP) ("OWCP") announced that, on Aug 31, 2020, the company will be holding a shareholders meeting to vote on a …

OWCP Stock Price | OWC Pharmaceutical Research Corp. Stock

Marketwatch.com Mar 26, 2021 · OWC Pharmaceutical Research Corp. OWC Pharmaceutical Research Corp. engages in the research and development of cannabis-based medical products for the treatment of myeloma and psoriasis. It focuses...

Team - OWC Pharmaceutical Research Corp

Owcpharma.com Mr. De-Saban has acted as CFO of OWC pharmaceutical research corp. and OWC Israel starting 6/16/2014 and until 6/12/2017. During this period, Mr. De-Saban has continuously reported to the SEC all needed reports. Mr. De-Saban studied for a Bachelor’s Degree in Economics at Tel-Aviv University and a degree as a CPA from Bar-Ilan university.

OWC PHARMACEUTICAL RESEARCH COR (OWCP) Company …

Finance.yahoo.com OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical...

OWC Pharmaceutical Research Stock Forecast, Price & News

Marketbeat.com OWC Pharmaceutical Research saw a increase in short interest in February. As of February 26th, there was short interest totaling 28,500 shares, an increase of 43.2% from the February 11th total of 19,900 shares. Based on an average trading volume of 12,562,900 shares, …

OWC Pharmaceutical Research Corp. (OWCP) Stock Message

Investorshub.advfn.com OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd. ("OWC"), of conducting medical research and clinical trials, in...

OWC Pharmaceutical Research News | Markets Insider

Markets.businessinsider.com OWC Pharmaceutical Research Corp. Announces World-Wide Expression of Interest in its Cannabis-based Topical Cream for Treatment of Psoriasis and other Skin Disorders PR Newswire 1,429d OWC...

OWCP - OWC Pharmaceutical Research Stock Competitors

Marketbeat.com OWC Pharmaceutical Research has higher earnings, but lower revenue than Terra Tech. Analyst Recommendations. This is a summary of current recommendations and price targets for OWC Pharmaceutical Research and Terra Tech, as provided by MarketBeat.com.

OWCP | OWC Pharmaceutical Research Corp. Profile | MarketWatch

Marketwatch.com OWC Pharmaceutical Research Corp. company facts, information and financial ratios from MarketWatch.

OWC Pharmaceutical Research Corp. (OWCP) Stock Price Today

Seekingalpha.com OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical...

OWC Pharmaceutical Research - Crunchbase Company Profile

Crunchbase.com OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., (collectively 'OWC' or the 'Company') conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and

OWCP:OTC US Stock Quote - OWC Pharmaceutical Research Corp

Bloomberg.com OWC Pharmaceutical Research Corporation is involved in the research and development for marijuana-based pharmaceuticals and treatments for a variety of medical issues.

OWC Pharmaceutical Research Corp - Stockhouse

Stockhouse.com OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders.

Why OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Is A

Mjglobalreport.com Jan 02, 2020 · OWC Pharmaceutical is an Israel-based cannabis research company. It is focused on research and development of cannabis-based medical products. The company’s work currently includes development of cannabis-based treatments for a variety of diseases and disorders such as multiple myeloma, psoriasis and fibromyalgia.

OWC Pharmaceuticals Research Corporation (PK) Share Price

Ih.advfn.com OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd. ("OWC"), of conducting medical research and clinical trials, in...

OWCP - OWC Pharmaceutical Research Corp. | Overview | OTC

Otcmarkets.com Feb 01, 2020 · OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd. ("OWC"), of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of medical cannabis specifically designed for the treatment of several illnesses/medical ...

OWC Pharmaceutical Research Corp. Letter to Shareholders

Finance.yahoo.com OWC Pharmaceutical Research Corp. (OTCQB: OWCP) ("OWCP") announced that, on Aug 31, 2020, the company will be holding a shareholders meeting to vote on a …

OWC Pharmaceutical Research Corp. 8-K Dec. 14, 2020 3:53

Seekingalpha.com On December 10, 2020, One World Cannabis Ltd. (“OWC-Israel”), an Israeli subsidiary of OWC Pharmaceutical Research Corp., filed a petition under the Insolvency and Rehabilitation Law, 2018 in ...

OWC Pharmaceutical Research Corp. Announces A New

Finance.yahoo.com Sep 14, 2020 · OWC Pharmaceutical Research Corp. (OTCQB: OWCP) ("OWCP") announced that, on Sep. 14, 2020, the Company signed an international distribution agreement with Can It …

OWCP Short Interest Ratio (OWC Pharmaceutical Research)

Marketbeat.com OWC Pharmaceutical Research saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 137,500 shares, an increase of 382.5% from the previous total of 28,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock ...

OWC Pharmaceutical Research Corp. Announces Special

Finance.yahoo.com OWC Pharmaceutical Research Mr. Ziv Turner, Chairman and CEO comments: "Through the company's unique and innovative products, which are supported by clinical studies and results, OWC is poised to...

OWC Pharmaceutical Research (OTCPK:OWCP) - Share price

Simplywall.st OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products.

OWC PHARMACEUTICAL RESEARCH CORP. : Changes in Control or

Marketscreener.com OWC PHARMACEUTICAL RESEARCH CORP. : Changes in Control or Registrant, Change in Directors or Principal Officers (form 8-K) 03/05/2021 | 06:32am EDT *: *: * Item 5.01 Changes in Control of Registrant. On December 13, 2020, Pursuant to Section 5(g) of the Certificate of ...

OWC Pharmaceutical Research Corp. 10-K/A Jul. 21, 2017 1

Seekingalpha.com We changed our name to OWC Pharmaceutical Research Corp. on December 9, 2014. We formed our fully owned subsidiary OWC in Israel on July 6, 2014. Our principal executive offices are located at 30 ...

Deleted from IHUB Post Date: - OWCP OWC Pharmaceutical

Investorshangout.com Deleted from IHUB Post Date: 2/20/2021 11:01:13 AM Board: OWC Pharmaceutical Research Corp. Reason: Off-Topic Just trying to set the record straight for those individuals that think or may be speculating that Ziv Turner is engaging services from a few that have posted on this board.

OWC Pharmaceutical Research Corp. Announces A New

Prnewswire.com Sep 14, 2020 · PETAH TIKVA, Israel, Sept. 14, 2020 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP) ("OWCP") announced that, on Sep. 14, 2020, the Company signed an international distribution ...

OWC Pharmaceutical Research Corp. to Report Top Line

Bloomberg.com Oct 07, 2019 · OWC Pharmaceutical Research Corp. to Report Top Line Results (TLR) for a Safety Study on Its Cannabis-based Tablets PR Newswire RAMAT GAN, Israel, Oct. 7, 2019 RAMAT GAN, Israel, Oct. 7, 2019 ...

OWC Pharmaceutical Research Corp. DEF 14A Nov. 18, 2019 7

Seekingalpha.com Nov 18, 2019 · OWC PHARMACEUTICAL RESEARCH CORP. 2 Ben Gurion Street. Ramat Gan, Israel 5257334 . To Our Stockholders: You are cordially invited to …

OWCP - Owc Pharmaceutical Research Corp News - Barchart.com

Barchart.com OWC Pharmaceutical Research Corp. (OTCQB: OWCP) ("OWC"), represented by its wholly-owned subsidiary, One World Cannabis Ltd., a company organized and existing under the laws of Israel ("OWC-Israel"), announced...

OWC Pharmaceutical Research Corp - dividend.com

Dividend.com OWC Pharmaceutical Research Corp Dividend policy None Price as of: MAR 23, 11:39 AM EDT $0.01 +0.0 +0.0% Watchlist Overview. Compare. Payout Estimate. New. Payout History. Trading Ideas. News & Research. Company Profile. Home Dividend Stocks Health Care Biotech Pharma Specialty Pharma OWC Pharmaceutical Research Corp (OWCP)

OWC Pharmaceutical Research Corp. Announces Special

Prnewswire.com PETACH TIKVA, Israel, July 29, 2020 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTC: OWCP) ("OWC"), announced that it will be holding a special meeting of stockholders to vote on a …

OWC Pharmaceutical Research Announces Update on Multiple

Prnewswire.com OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., (collectively "OWC" or the "Company") conducts medical research and clinical trials to ...

OWCP | OWC Pharmaceutical Research Corp. Company Profile

Wsj.com OWC Pharmaceutical Research Corp. engages in the research and development of cannabis-based medical products for the treatment of myeloma and psoriasis. It focuses on the provision of consulting ...

OWCP | OWC Pharmaceutical Research Corp. Analyst Estimates

Wsj.com OWC Pharmaceutical Research Corp. analyst ratings, historical stock prices, earnings estimates & actuals. OWCP updated stock price target summary.

OWC Pharmaceutical Research Corp and STENOCARE to Enter

Prnewswire.com OWC Pharmaceutical Research CEO Mordechai Bignitz commented: "STENOCARE is a strong match for OWC with its unique focus on pharma-grade production and distribution of medical cannabis in ...

OWCP | OWC Pharmaceutical Research Corp. Stock Price

Wsj.com View the latest OWC Pharmaceutical Research Corp. (OWCP) stock price, news, historical charts, analyst ratings and financial information from WSJ.

OWC Pharmaceutical Research Corp Archives - MMJObserver

Mmjobserver.com Nov 25, 2019 · OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has obtained expressions of interest from the medical and scientific communities globally as a result of its recently reported positive initial clinical efficacy tests data of its topical cream targeting Psoriasis. The details. OWC Pharmaceutical’s scientific team, directed by the famous Dr. Yehuda Baruch, the firm’s Chief …

OWCP News Today (OWC Pharmaceutical Research) | MarketBeat

Marketbeat.com OWC Pharmaceutical Research Corp (OWCP) nasdaq.com - November 3 at 12:39 AM: OWC Pharmaceutical Research Corp. Announces A New Distribution Agreement With Can It Industries, Florida US finance.yahoo.com - September 14 at 12:30 PM: OWC Pharmaceutical Research Corp. Letter to Shareholders for Upcoming Proxy Voting finance.yahoo.com - August 19 at ...

OWC Pharmaceutical Research Corp. Letter to Shareholders

Prnewswire.com PETAH TIKVA, Israel, Aug. 19, 2020 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP) ("OWCP") announced that, on Aug 31, 2020, the …

OWCP | OWC Pharmaceutical Research Corp. Financial

Wsj.com OWC Pharmaceutical Research Corp. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View OWCP financial statements in full.

Short Interest in OWC Pharmaceutical Research Corp

Theenterpriseleader.com Mar 01, 2021 · OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP) was the target of a large growth in short interest in February. As of February 12th, there was short interest totalling 19,900 shares, a growth of 4,875.0% from the January 28th total of 400 shares. Based on an average trading volume of 23,456,100 shares, the days-to-cover ratio is currently 0.0 […]

OWC Pharmaceutical Research Corp. Announces Special

Nasdaq.com PETACH TIKVA, Israel, July 29, 2020/ PRNewswire/-- OWC Pharmaceutical Research Corp., announced that it will be holding a special meeting of stockholders to vote on a reverse stock split at a ...

OWC Pharmaceutical Research Corp. OWCP (U.S.: OTC)

Wsj.com Alon Sinai Chief Operating Officer, OWC Pharmaceutical Research Corp. Currently, Alon Sinai holds the position of Chief Operating Officer for OWC Pharmaceutical Research Corp.

OWCP Stock Price & Charts | OWC Pharmaceutical Research

Ycharts.com Description: OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders.